2 minute read
Facilitating advanced therapies by streamlining the value chain
Launched in 2012 and headquartered in Cardiff, UK and with offices in the USA, TrakCel provides software solutions and professional services that facilitate the orchestration of advanced cell therapies from early-stage clinical trials to commercialisation and beyond by simplifying the complex value chain associated with these treatments.
Working with clients across a broad range of therapy classes including autologous, allogeneic and personalised cancer vaccines, the second-generation platform OCELLOS by TrakCel allows therapy developers to manage and monitor the supply chain, from patient enrolment, through temperature-controlled logistics, to manufacturing and delivery of the final drug product to the patient.
These lifesaving treatments are subject to multiple, complex processes and legislations to ensure that they are safe and effective for patients. Combined with the nature of the materials being worked with and the health of the patient, all of this needs to be accomplished as quickly, efficiently and safely as possible with a full record of every stage of the supply chain journey. OCELLOS puts shipping information, Chain of Identity, Chain of Custody and audit information at the fingertips of the relevant platform users, integrating with systems such as shipping and labelling to highlight if conditions go out of range and to help prevent errors that might lead to the product being unusable or, at worst, incorrectly delivered, potentially causing harm to the patient.
In medicine’s most complex value chain, the successful delivery of advanced therapies presents a unique set of challenges and relies upon a connected, compliant and scalable value chain. With multiple stakeholders involved in the delivery of successful
OCELLOS is a new generation SAAS platform built on Salesforce.com which was launched to give customers the flexibility of a highly scalable and modular solution. The platform can be quickly and easily configured using ‘clicks not code’ methodology, and deployed to meet process and therapy requirements as well as exception management in a cost-effective and timely manner in a highly regulated environment.
treatment, issues can arise from many areas, including manufacturing challenges and constraints or the incorrect delivery of samples or treatments, and the need to see the journey in its entirety has never been as pressing. TrakCel use the phrase ‘cellular orchestration’ for this very reason and are dedicated to coordinating the services, experience and knowledge of the various stakeholders across the partner ecosystem that work together to deliver these life-changing therapies.
So, what is next for TrakCel? There is always a patient at the end of everything we do, so we continue to recruit talented people to further develop and deliver OCELLOS, ensuring we meet and exceed the needs of an ever-changing and developing industry. We also continue to broaden our partner network, where integrations simplify the process of connecting these vital treatments to the patients who need them.
